Copenhagen Bioengineering ApS: Financial statements 2024
CVR: 37640549
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Copenhagen Bioengineering ApS (CVR 37640549) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 136,920 and a net result of DKK 27,263 compared with DKK 76,184 the year before. That is a decrease of 26.9% compared with the year before. Equity in the 2024 report amounted to DKK 1,018,573. The solvency ratio was 97.5%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 136,920
- Profit/Loss
- DKK 27,263
- Equity
- DKK 1,018,573
- Total Assets
- DKK 1,045,051
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 137 t. | 27 t. | 1 mio. | 1 |
| 2023 | - | 187 t. | 76 t. | 991 t. | 1 |
| 2022 | - | -484 t. | -414 t. | 915 t. | - |
| 2021 | - | 243 t. | 158 t. | 1.3 mio. | - |
| 2020 | - | 693 t. | 514 t. | 1.2 mio. | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Copenhagen Bioengineering ApS has published its annual report for 2023. Gross profit came to DKK 187,399, and the net result was DKK 76,184.
About Copenhagen Bioengineering ApS
Copenhagen Bioengineering ApS is a Danish company of the type Anpartsselskab based in Hårlev, founded in 2016. The company is registered under the industry Leasing af intellektuelle ejendomsrettigheder og lignende produkter, dog ikke ophavsretsbeskyttede værker. The management consists of Phillip Falkenløve Kaaber and Marco Falkenløve Kaaber. The board consists of Niels Juul Jensen. The company's owners include Strukturforsyningen ApS, Holtug Holding ApS and M.F. Kaaber Holding ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -90,560 and a net result of DKK -210,012 compared with DKK 27,263 the year before. Equity in the 2025 report amounted to DKK 808,561.